Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093-203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2-093) for acute manic episodes associated with biopolar I disorder

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Robertson B, Grunze H, Versavel M, Costa R, Almeida L, Soares da Silva P

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Bipolar Disorders: 4th Biennial Conference of the International Society for Bipolar Disorders

Year of Conference: 2010

Pages: 46

ISSN: 1398-5647

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/j.1399-5618.2010.00782.x

DOI: 10.1111/j.1399-5618.2010.00782.x

Library holdings: Search Newcastle University Library for this item

ISBN: 16005511

ePrints